FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
Feds wait for lowered vaccine efficacy to recommend COVID-19 booster shots
By
Alicia Lasek
Jul 22, 2021
COVID-19 vaccine booster shots will not be necessary until mRNA vaccines become less effective, federal health officials say. But immunocompromised Americans are potential near-term recipients, they told...
Boosters on the way: LTC residents, healthcare workers may top fed’s list after CDC approves 3rd shot
By
Alicia Lasek
Aug 16, 2021
The Biden administration has secured 100 million COVID-19 vaccine doses as part of a strategy to provide additional shots to already vaccinated priority groups this fall, investigators have been told....
Breaches of basic infection control practices — why?
By
Jacqueline Vance, RNC, CDONA/LTC
Jul 30, 2012
Basic infection prevention and control isn’t rocket science. It is essentially following some general guidelines. Some of them pretty simplistic. Not too hard right? You would think, but …